Trial intelligence / Profile preview

Interscalene Block Versus Anterior Suprascapular Nerve Block for Shoulder Surgery

NCT07831096Recruiting

Sponsor
ASST Sette Laghi
Start
Jan 2026
Primary completion
Feb 2027
Countries
1
01

Overview

Randomised, single-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by ASST Sette Laghi. Primary endpoint: Postoperative pain intensity at 6 hours after surgery. Started Jan 2026; status: recruiting.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07831096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07831096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call